Patent details

EP2502632 Title: PREVENTATIVE AGENT AND/OR THERAPEUTIC AGENT AND/OR EXACERBATION-SUPPRESSING AGENT FOR HUMAN KNEE OSTEOARTHRITIS

Basic Information

Publication number:
EP2502632
PCT Application Number:
PCT/JP/2010/069742
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP108314683
PCT Publication Number:
WO/2011/062073
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
PREVENTATIVE AGENT AND/OR THERAPEUTIC AGENT AND/OR EXACERBATION-SUPPRESSING AGENT FOR HUMAN KNEE OSTEOARTHRITIS
French Title of Invention:
AGENT PROPHYLACTIQUE ET/OU AGENT THÉRAPEUTIQUE ET/OU AGENT DE SUPPRESSION D'EXACERBATION POUR ARTHROSE DE GENOU HUMAIN
German Title of Invention:
PRÄVENTIVES MITTEL UND/ODER THERAPIEMITTEL UND/ODER VERSCHLIMMERUNGSUNTERDRÜCKUNGSMITTEL FÜR OSTEOARTHRITIS IM MENSCHLICHEN KNIE
SPC Number:

Dates

Filing date:
05/11/2010
Grant date:
28/12/2016
EP Publication Date:
28/12/2016
PCT Publication Date:
26/05/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/09/2012
EP B1 Publication Date:
28/12/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/11/2017
Expiration date:
05/11/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/11/2010
 
 

Name:
Asahi Kasei Pharma Corporation
Address:
1-105 Kanda Jinbocho Chiyoda-ku, Tokyo 101-8101, Japan (JP)

Inventor

1

Name:
ISHIZUYA Toshinori
Address:
Japan (JP)

2

Name:
KURODA Tatsuhiko
Address:
Japan (JP)

Priority

Priority Number:
262214 P
Priority Date:
18/11/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/29;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages